Dynamin-1 is a potential mediator in cancer-related cognitive impairment
Dynamin-1 (DNM1) is crucial for synaptic activity, neurotransmission, and associative memory, positioning it as a potential biomarker of cancer-related cognitive impairment (CRCI), a neurological consequence of cancer treatment characterized by memory loss, poor concentration, and impaired executive...
| 出版年: | Neurotherapeutics |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Elsevier
2025-01-01
|
| 主題: | |
| オンライン･アクセス: | http://www.sciencedirect.com/science/article/pii/S1878747924001673 |